Alkaloid AD Skopje

ALK

MKALKA101011

Pharmaceuticals

End-of-day quote MACEDONIAN S.E. Other stock markets
- ^MKD	-

Jan. 15	Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Alkaloid AD Skopje Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Alkaloid Skopje : Annual shareholders meeting

March 03, 2017 at 04:48 am EST

03.03.2017

Dear shareholders,

Alkaloid AD Skopje announces that the Annual shareholders meeting will be held on 03.04.2017 at 08:00 hours at the premises of the Company, on Blvd. Aleksandar Makedonski 12, Skopje, Republic of Macedonia.

At its meeting held on 02.03.2017, the Management Board of Alkaloid AD Skopje reached a Draft-Decision for dividend payment for 2016. The amount of the dividend per share purposed to the annual shareholders meeting is MKD 250.00 gross, or MKD 225.00 net, which is an increase of 8.7% compared to the dividend per share for 2015 in amount of MKD 230.00 gross, or MKD 207.00 net.

Dividend shall be paid on shareholders transaction accounts.

For all the details please visit (www.mkverzijanasajtot)

Alkaloid AD Skopje

Management board

Alkaloid AD Skopje published this content on 03 March 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 03 March 2017 09:48:09 UTC.

Original documenthttp://www.alkaloid.com.mk/investor-news-ns_article-annual-shareholders-meeting-2017.nspx

Public permalinkhttp://www.publicnow.com/view/9FCB7F3F867BDA5197EFEDDD3D51FA0AF5DBBF77

Latest news about Alkaloid AD Skopje

Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 14	CI
Alkaloid AD Skopje Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-26	CI
Alkaloid AD Skopje Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-14	CI
Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-26	CI
Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2021	22-01-14	CI
Alkaloid Ad Skopje Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-29	CI
Alkaloid Ad Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Alkaloid Ad Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-25	CI
Alkaloid Ad Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-14	CI
Alkaloid Ad Reports Earnings Results for the Half Year Ended June 30, 2020	20-07-30	CI
Alkaloid Ad Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-30	CI
Alkaloid AD's Equity Buyback announced on March 12, 2020, has expired.	20-04-06	CI
Alkaloid AD(MSE:ALK) commences an Equity Buyback for 10% of its issued share capital, under the authorization approved on April 8, 2019.	20-03-12	CI
Alkaloid Ad Reports Earnings Results for the Full Year Ended December 31, 2019	20-02-28	CI
Alkaloid Ad Skopje Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-30	CI
Alka-Lab announced that it has received €0.4 million in funding from Alkaloid AD	19-07-22	CI
Alkaloid Ad Reports Earnings Results for the Full Year Ended December 31, 2018	19-02-27	CI
ICC International Cannabis Corp. (CNSX:WRLD.U) acquired an unknown stake in Alkaloid AD.	19-01-23	CI
Alkaloid Ad Skopje Reports Earnings Results for the Nine Months Ended September 30, 2018	18-10-31	CI
Alkaloid Reports Consolidated Earnings Results for the First-Quarter of 2017	17-04-27	CI
Alkaloid Reports Unaudited Consolidated and Standalone Earnings Results for the Year Ended December 2016	17-02-28	CI
Alkaloid Reports Consolidated Financial Results for the First Nine Months Ended September 2016	16-11-03	CI
Alkaloid AD Reports Unaudited Consolidated Earnings Results for the First Half Ended June 2016	16-07-29	CI
Alkaloid Reports Consolidated Earnings Results for the First Quarter Ended March 2016	16-04-28	CI
Alkaloid Plans to Expand Presence in Russian Market Via Serbia	16-03-31	CI

Chart Alkaloid AD Skopje

Duration

Period

More charts

Company Profile

Alkaloid AD Skopje is a Macedonia-based company active in the pharmaceutical sector. It is engaged in the manufacturing and distribution of pharmaceuticals, the processing of herbal materials and the production of cosmetics, tea, chemical products and coating agents. It operates through two divisions: Pharmaceuticals, and Chemicals, Cosmetics and Botanicals. The Companyâs product range includes human drugs, x-ray films, haemodialysis solutions, pharmaceutical raw materials, animal health products, perfumes, household cosmetics, skin, teeth and hair care products, tea and alimentary products. It also operates a development institute for analysis, research and quality control, warehouses and laboratories. The Company operates more than 13 subsidiaries in such countries as Croatia, Serbia, Slovenia, Bosnia and Herzegovina, Bulgaria, Kosovo, the Untied States, Montenegro and the Russian Federation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ALKALOID AD SKOPJE	0.00%	0
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.40%	44.1B
OTSUKA HOLDINGS CO., LTD.	+15.73%	21.97B
CIPLA LIMITED	+8.10%	13.27B
SANDOZ GROUP AG	+6.06%	13.22B
ZYDUS LIFESCIENCES LIMITED	+35.95%	11.36B
ONO PHARMACEUTICAL CO., LTD.	-10.63%	7.07B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+7.71%	5.23B